Condition

Secondary Acute Myeloid Leukemia clinical trials and research

Research outlook What's coming for Acute myeloid leukemia: the next 6 months to 5 years

As of November 12, 2026, Find a Trial lists 8 Secondary Acute Myeloid Leukemia clinical trials that are recruiting, at sites in 3 countries (most in United States (6), China (1), Germany (1)). By phase: Phase 1 (3), Phase 1/2 (3), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Secondary Acute Myeloid Leukemia clinical trials

StudyPhaseWhereStatusRegistered
Decitabine plus FLAG‑Ida chemotherapy and total‑body irradiation before donor stem cell transplant for adults with high‑risk myeloid cancers Phase 1/2 Seattle, Washington Recruiting Apr 15, 2025
Combining SNDX-5613 with standard chemotherapy for newly diagnosed acute myeloid leukemia Phase 1 Orange, California and 22 other locations Recruiting Jun 2, 2023
Using Venetoclax with FLAMSA and Treosulfan for Blood Stem Cell Transplantation in Certain Blood Cancers Phase 1/2 Aachen, North Rhine-Westphalia and 5 other locations Recruiting Apr 11, 2023
CAR T Cell Therapy for Recurrent or Refractory Acute Myeloid Leukemia Phase 1 Duarte, California Recruiting Jan 5, 2023
Using umbilical cord blood stem cells with azacitidine for advanced blood cancers Phase 1/2 Nanjing, Jiangsu Recruiting Oct 18, 2022
Using edetate calcium disodium or succimer to treat acute myeloid leukemia or myelodysplastic syndrome during chemotherapy Phase 1 Houston, Texas Recruiting Aug 15, 2018
Personalized NK cell therapy after umbilical cord blood transplant for leukemia Phase 2 Houston, Texas Recruiting Apr 5, 2016
Combining cladribine, idarubicin, cytarabine, and venetoclax for treating certain blood cancers Phase 2 Houston, Texas Recruiting Apr 16, 2014

All recruiting trials (8)

Related topics

Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Biphenotypic LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelomonocytic LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Myeloid LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Myelodysplastic SyndromeRefractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Quick answers

How many Secondary Acute Myeloid Leukemia clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (6 trials), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 1/2: 3, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.